Genetic screening for HCM a "highly cost-effective" option
Home phototherapy: a shining light for psoriasis
Benchmark cost effectiveness for "off label" drug-eluting stents
Adding zoledronic acid to endocrine therapy highly cost effective
No support for preventive primary care outreach for the elderly
Barriers to opioid analgesics for cancer pain evident in East Europe
cCBT seems worth it for depression at first glance...
Higher volume hospitals reduce mortality in common conditions
ECG plus echo may be worth it for diagnosing LVH in US
Insurance worries cause delays in seeking treatment for AMI
Cladribine reduces healthcare resource use in MS
Extending drug supply improves adherence
Cost-effective antiretroviral therapy in Columbia
Rosuvastatin best cost option for dyslipidaemia in Mexico
Psoriasis: a significant burden to employers
School-based asthma screening not likely to be worth it in the US
Patients not receiving appropriate treatment
Third-generation chemo plus G-CSF hits the mark in Japan
Total annual direct costs for overweight and obese Australians in 2005 may have been as high as $A21 billion
Universal prenatal screening for SMA doesn't stack up in the US
Massachusetts law change brings health insurance to many more
Postpartum contraception for new Latina immigrants to the US saves costs
Endovascular repair not best option for abdominal aortic aneurysm
Current physician cost-profiling methods misleading in the US
Prescribing of docetaxel for castrate-resistant prostate cancer has increased following publication of the TAX327 study and NICE recommendations,
Taxing junk food could provide big gains for US health system
NCCN updates guidelines for AML
Guidelines for the diagnosis and management of patients with thoracic aortic disease have been released
ASCO updates guidelines on breast cancer risk reduction
BDNF Val66Met polymorphism affects HRQoL in MDD
HRQoL predicts survival in gastric cancer
Mometasone/formoterol provides clinically meaningful improvement in QOL
The International Society for Heart and Lung Transplantation (ISHLT) has issued new guidelines in an attempt to standardise care
Global drug sales to reach $US1.1 trillion by 2014
Strong growth predicted for ovarian cancer & IBS drug markets
Wasteful pharmacy-related spending costs US billions